Signs and Symptoms of Bone Cancer
The cardinal presenting symptom of bone cancer is localized pain that characteristically occurs at rest or during the night—this "night pain" is a critical red flag requiring immediate investigation. 1
Primary Clinical Presentations
Pain Characteristics
- Pain is the most common presenting symptom, with night pain being particularly suspicious for malignancy 1
- Pain intensity may vary, but the key distinguishing feature is that it occurs at rest or during nighttime, unlike mechanical musculoskeletal injuries 1
- The average duration of symptoms before patients seek medical attention is approximately 3 months 1
- Critical pitfall: A history of recent injury does NOT exclude bone cancer and must not delay appropriate diagnostic workup 1
Localized Physical Findings
- Swelling or palpable mass at the affected site is common 2, 1
- The mass should be assessed for size, consistency, mobility, and relationship to underlying bone 1
- Regional and local lymph nodes should be examined 1
Constitutional Symptoms (Particularly Ewing Sarcoma)
- Fever, weight loss, and fatigue may be present, especially with Ewing sarcoma—this distinguishes it from other bone sarcomas 2
- Elevated serum lactate dehydrogenase (LDH) and leukocytosis may be noted on laboratory studies 2
Tumor-Specific Presentations by Location
Long Bone Involvement
- Osteosarcoma most frequently affects the metaphysis of long bones, particularly around the knee (distal femur and proximal tibia) 1, 3
- Ewing sarcoma affects the diaphysis when arising in long bones, with 50% of cases occurring in extremity bones 2, 1
- Adamantinoma is highly specific for the tibial shaft (medial or distal portions) 1
Axial Skeleton Involvement
- Pelvic or axial lesions typically present later in the disease course because pain has a more insidious onset and occurs when the tumor has reached significant size 2
- Ewing sarcoma commonly affects pelvic bones and bones of the chest wall 2
Epiphyseal Involvement
- Giant cell tumor of bone usually occurs at the epiphyses of long bones next to joints in patients aged 20-40 years 1
Radiographic Findings That Suggest Malignancy
Plain radiography in two planes is the first-line investigation 1
Suspicious radiographic features include:
- Poorly marginated lesion on plain radiograph 2
- Bone destruction or mottled appearance 2
- New bone formation 1
- Periosteal reaction (classic "onion skin" appearance in Ewing sarcoma) 2
- Soft tissue swelling 1
- Cortical destruction and loss of medullary bone trabeculations (chondrosarcoma) 2
Age-Based Diagnostic Approach
Under 5 Years
- Destructive bone lesions more likely represent metastatic neuroblastoma or Langerhans cell histiocytosis rather than primary bone cancer 1
Ages 5-40 Years
- Primary bone sarcoma is the most likely diagnosis for aggressive, symptomatic bone lesions 2, 1
- Referral to an orthopedic oncologist should be considered before further workup 2
Over 40 Years
- Metastatic carcinoma or myeloma becomes the most common diagnosis and should be investigated first 2, 1
- Initial workup should include history and physical, bone scan, chest x-ray, CT chest/abdomen/pelvis with contrast, and additional testing such as serum protein electrophoresis, CBC, comprehensive metabolic panel, PSA, or mammogram as indicated 2
Critical Laboratory Abnormalities
Before definitive treatment, obtain:
- Complete blood count (CBC) 2
- Comprehensive metabolic panel with calcium to assess for hypercalcemia 2
- Lactate dehydrogenase (LDH)—elevated levels suggest worse prognosis 2
- Alkaline phosphatase (ALP) 2
When to Refer Urgently
Immediate referral to a bone sarcoma center is required if: 1
- X-ray shows bone destruction, new bone formation, periosteal swelling, or soft tissue swelling
- Patient is under 40 years with suspected primary bone malignancy
- Any patient presents with night pain and suspicious radiographic findings
Common pitfall to avoid: Delaying referral while awaiting additional imaging—patients with radiographic suspicion should be referred immediately to a specialized center for coordinated staging and biopsy 2, 1